Medrone Indications/Uses

Methylprednisolone Sodium Succinate for Injection is indicated for intramuscular or intravenous use in the following conditions: Endocrine Disorders: Primary or secondary adrenocortical insufficiency, acute adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis.
Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy), acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, acute and subacute bursitis. For the treatment of dermatomyositis, temporal arteritis, polymyositis and systemic lupus erythematosus.
Collagen Diseases: During exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis.
Dermatologic Diseases: Pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative erythroderma, bullous dermatitis herpetiformis, mycosis fungoides.
Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, contact dermatitis, atopic dermatitis, serum sickness, seasonal or perennial allergic rhinitis, drug hypersensitivity reactions, transfusion reactions.
Gastrointestinal Diseases: Ulcerative colitis (systemic therapy), regional enteritis (systemic therapy).
Respiratory Diseases: Symptomatic sarcoidosis, berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate anti-tuberculous chemotherapy, Loeffler's syndrome not manageable by other means.
Hematologic Disorders: Acquired (autoimmune) hemolytic anemia, selective cases of secondary thrombocytopenia in adults, erythroblastopenia (red blood cell anemia), congenital (erythroid) hypoplastic anemia, idiopathic thrombocytopenic purpura in adults (intravenous administration only). Intramuscular administration is contraindicated.
Neoplastic Disorders: For palliative management of leukemias and lymphomas.
Renal Diseases: To induce or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
Nervous System: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy.